Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IMNM
IMNM logo

IMNM News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMNM News

Immunome Grants Stock Options to New Employees

Mar 05 2026Yahoo Finance

Opaleye Management Sells Entire Stake in Immunome for $37.3 Million

Mar 04 2026Fool

Opaleye Management Exits Entire Stake in Immunome

Mar 04 2026NASDAQ.COM

Immunome Reports FY Loss and Declining Revenue Amid Public Offering

Mar 03 2026seekingalpha

Redmile Group Increases Stake in Immunome

Feb 22 2026Fool

Redmile Group Increases Immunome Holdings

Feb 22 2026NASDAQ.COM

Wall Street Analysts Adjust Ratings

Feb 12 2026Benzinga

Precision Biologics Market Awakens to $71 Billion Opportunity

Feb 05 2026Globenewswire

IMNM Events

No data

No data

IMNM Monitor News

Immunome Inc experiences significant drop amid fundraising announcement

Dec 17 2025

Immunome Inc Reports Positive Phase 3 Trial Results for Varegacestat

Dec 15 2025

IMNM Earnings Analysis

No Data

No Data

People Also Watch